This conference will provide an international forum on nanomedicine, cancer therapy, safety assessment, and sustainability, bringing together advances in biomedical research, nanotechnology, and health sciences. The conference will showcase the latest developments at the multidisciplinary frontier of innovative therapeutic strategies, safety evaluation methods, and sustainable approaches in nanomedicine.

The conference will cover areas related to nanomedicine, cancer therapy, safety assessment, and sustainability, such as the synthesis and chemical functionalization of nanoparticles for biomedical applications, predictive models of nanomaterial toxicity and cancer, organ-on-chip systems, omics technologies, immunotherapy, gene therapy, sustainability in biomedical research, as well as the social and ethical relations of animal research.

The rich scientific program of this conference consists of 6 invited lectures, 20 contributed talks, and a poster session on Wednesday 16^th September afternoon/evening (6-8 pm). The conference will bring together about 80 international scientific participants.

A panel discussion with policymakers about the Future of Cancer Research and Treatment in Europe: Bridging Science, Policy and Innovation will be organized.

This conference is a great opportunity to bring together researchers from different fields, exchange ideas, and discuss how advanced molecular and nanoscale systems can contribute to addressing key societal challenges.

- Dr. Alberto BIANCO (CNRS, Strasbourg, France)
Carbon nanomaterials, nanomedicine & nanomaterial safety and biodegradability 
https://ibmc.cnrs.fr/en/laboratoire/i2ct-en/equipes/therapeutic-multifunctional-carbon-and-2d-nanomaterials/

- Prof. Amaia CIPITRIA (Biogipuzkoa Health Research Institute, San Sebastián, Spain)
Biomaterials for tissue regeneration and disease modeling, cancer dormancy and bone metastasis & bioengineering in clinical oncology
https://cipitrialab.com/

- Prof. Iseult LYNCH (University of Birmingham, UK)
Environmental interactions of nanoparticles with biological entities & predictive modes of nanomaterials toxicity
https://www.birmingham.ac.uk/staff/profiles/gees/lynch-iseult.aspx

- Dr. Reuben MESSAGE (The University of Edinburgh, UK)
Social study of mammalian synthetic biology, with a focus on research cultures & social and ethical relations of animal research 
https://www.sps.ed.ac.uk/staff/reuben-message

- Dr. Daina ROMEO
Roche, Zürich (Switzerland)
Risk governance framework for nanomaterials & life cycle impact assessment of nanoparticles
linkedin.com/in/daina-romeo-

- Dr. Stefaan VERBRUGGEN (Queen Mary University of London, UK)
Predictive in vitro models of cancer metastasis (e.g., organ-on-chips)
https://www.sems.qmul.ac.uk/staff/s.verbruggen/